Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.26
+0.06 (1.15%)
At close: Apr 14, 2026, 4:00 PM EDT
5.36
+0.10 (1.90%)
After-hours: Apr 14, 2026, 4:14 PM EDT

Journey Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
61.8656.1379.1873.6763.13
Revenue Growth (YoY)
10.20%-29.11%7.48%16.69%41.77%
Cost of Revenue
20.9220.8822.8930.7832.08
Gross Profit
40.9335.2656.2942.8931.05
Selling, General & Admin
44.3740.243.9159.4739.83
Depreciation & Amortization Expenses
4.263.423.77--
Research & Development
0.489.867.5410.9416.56
Other Operating Expenses
--4.553.14-9.54
Total Operating Expenses
49.1148.9358.3670.4165.93
Operating Income
-8.17-13.68-2.07-27.52-34.88
Interest Income
0.590.760.320.060
Interest Expense
-3.7-2.7-1.7-2.02-7.03
Other Non-Operating Income (Expense)
-0.091.01-0.18-0.09-0.45
Total Non-Operating Income (Expense)
-3.2-0.93-1.56-2.05-7.48
Pretax Income
-11.37-14.61-3.63-29.57-42.36
Provision for Income Taxes
0.060.060.220.061.63
Net Income
-11.43-14.67-3.85-29.63-43.99
Net Income to Common
-11.43-14.67-3.85-29.63-43.99
Shares Outstanding (Basic)
2420181810
Shares Outstanding (Diluted)
2420181810
Shares Change (YoY)
19.90%12.06%4.00%72.15%-6.02%
EPS (Basic)
-0.47-0.72-0.21-1.69-4.32
EPS (Diluted)
-0.47-0.72-0.21-1.69-4.32
Shares Outstanding
27.1422.1519.3217.7717.32
Free Cash Flow
-12.44-9.135.24-13.53-2.18
Free Cash Flow Per Share
-0.51-0.450.29-0.77-0.21
Gross Margin
66.17%62.81%71.09%58.23%49.18%
Operating Margin
-13.21%-24.36%-2.62%-37.35%-55.25%
Profit Margin
-18.48%-26.14%-4.87%-40.22%-69.68%
FCF Margin
-20.11%-16.26%6.62%-18.37%-3.45%
EBITDA
-3.83-10.161.78-23.15-32.32
EBITDA Margin
-6.19%-18.10%2.25%-31.43%-51.19%
EBIT
-8.17-13.68-2.07-27.52-34.88
EBIT Margin
-13.21%-24.36%-2.62%-37.35%-55.25%
Effective Tax Rate
-0.53%-0.42%-6.08%-0.21%-3.86%
Updated Mar 25, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q